The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM)

Journal of the Neurological Sciences

Volumn 148, Issue 1, 1997, Pages 87-94

  Hatae, Tomoko ^a   Hara, Hideo ^a   Kobayashi, Takurou ^a   Watanabe, Takeshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

competitive PCR; cytokines; rolipram; tumor necrosis factor alpha (TNF )

Indexed keywords

CYTOKINE; GAMMA INTERFERON; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINAL CORD DISEASE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; GENE EXPRESSION; HTLV-I INFECTIONS; HUMANS; PARAPARESIS, TROPICAL SPASTIC; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; POLYMERASE CHAIN REACTION; PYRROLIDINONES; RNA, MESSENGER; ROLIPRAM; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031149099     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)05337-3     Document Type: Article

References (40)

1. Barten, D.M. and Ruddle, N.H. (1994) Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol., 51: 123-133.
2. Cavender, D.E., Edelbaum, D. and Ziff, M. (1989) Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am. J. Pathol., 134: 551-560.
3. Chan, J.Y., Salmon, D.J., Nimer, S.D., Golde, D.W. and Gasson, J.C. (1986) Regulation of expression of human granulocytes/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA, 83: 8669-8673.
4. Essayan, D.M., Huang, S.K., Undem, R.J., Kagey-Sobotka, A. and Lichtenstein, L.M. (1994) Modulation of antigen and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J. Immunol., 153: 3408-3416.
5. Gazdar, A.F., Carney, D.N., Bunn, P.A., Russell, E.K., Jaffe, E.S., Schechter, G.P. and Guccion, J.G. (1980) Mitogen requirements for the in vitro propagation of cutaneous T cell lymphoma. Blood, 55: 409-417.
6. Genain, C.P., Roberts, T., Davis, R.L., Nguyen, M-H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J. and Hauser, S.L. (1995) Prevention of autoimmune demyelination in non-human primates by cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA, 92: 3601-3605.
7. Huber, C., Batchelor, J.R., Fuchs, D., Hausen, A., Lang, A., Niderwieser, D., Reibnegger, G., Swetly, P., Troppmair, J. and Wachter, H. (1984) Immune response-associated production of neopterin; release from macrophages primarily under control of interferon-gamma. J. Exp. Med., 160: 310-316.
8. Hughes, C.C.W., Male, D.K. and Lantos, P.L. (1988) Adhesion of lymphocytes to cerebro microvascular cells: effect of interferon-gamma, tumor necrosis factor and interleukin-1. Immunology, 64: 677-681.
9. Itoyama, Y., Kira, J., Fujii, N., Goto, I. and Yamamoto, N. (1989) Increase in helper-inducer T-cells and activated T-cells in HTLV-I associated myelopathy. Ann. Neurol., 26: 257-262.
10. Itoyama, Y., Minato, S., Kira, J., Goto, I., Sato, H., Okochi, K. and Yamamoto, N. (1988) Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I associated myelopathy. Neurology, 38: 1302-1307.
11. Iwasaki, Y. (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J. Neurol. Sci., 96: 103-123.
12. Jacobson, S., Raine, C.S., Mingioli, E.S. and McFarlin, D.E. (1988) Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature, 331: 540-543.
13. Kambayashi, T., Jacob, C.O., Zhou, D., Mazurek, N., Fong, M. and Strassmann, G. (1995) Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol., 155: 4909-4916.
14. Kuroda, Y. and Matui, M. (1993) Cerebrospinal fluid interferon-gamma is increased in HTLV-I associated myelopathy. J. Neuroimmunol., 42: 223-226.
15. McCarron, R.M., Wang, L., Racke, M.K., McFarlin, D.E. and Spatz, M. (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol., 43: 23-30.
16. Moore, G.R.W., Traugott, U., Scheinberg, L.C. and Raine, C.S. (1989) Tropical spastic paraparesis: A model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann. Neurol., 26: 523-530.
17. Nakamura, S., Nagano, I., Yoshioka, M., Shimazaki, S., Onodera, J. and Kogure, K. (1993) Detection of tumor necrosis factor-positive cells in cerebrospinal fluid of patients with HTLV-I associated myelopathy. J. Neuroimmunol., 42: 127-130.
18. Nakamura, T., Shirabe, S., Ichinose, K., Nishiura, Y., Watanabe, H., Suenaga, A., Yoshimura, T., Tsujihata, M. and Nagataki, S. (1995) Pentoxifylline treatment in HTLV-I-associated myelopathy. Intern. Med., 34: 460.
19. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M. and Tara, M. (1986) HTLV-I-associated myelopathy. A new clinical entity. Lancet, (i): 1031.
20. Popovic, M., Lange-Wantzin, G., Sarin, P.S., Mann, D. and Gallo, R.C. (1983) Transformation of human umbilical cord blood T cells by human T-cell leukemia/lyphoma virus. Proc. Natl. Acad. Sci. USA, 80: 5402-5406.
21. Prabhakar, U., Lipshutz, D., Bartus, J.O., Silvjak, M.J., Smith, E., 3rd., Lee, J.C. and Esser, K.M. (1994) Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int. J. Immunopharmacol., 16: 805-816.
22. Roman, G.C. and Osame, M. (1988) Identity of HTLV-I associated tropical spastic paraparesis and HTLV-I associated myelopathy. Lancet, (i): 651.
23. Salahuddin, S.Z., Markham, P.D., Lindner, S.G., Gootenberg, J., Popovic, M., Hemmi, H., Sarlin, P.S. and Gallo, R.C. (1984) Lymphokine production by cultured human T cells transformed by human-T cell-leukemia-lymphoma virus-I. Science, 223: 703-707.
24. Satoh, J., Kim, S.U., Kastrukoff, L.F. and Takei, F. (1991) Expression and induction of intracellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigen on cultured murine oligodendrocytes and astrocytes. J. Neurosci. Res., 29: 1-12.
25. Sawada, M., Suzumura, A., Kondo, N. and Marunouchi, T. (1992) Induction of cytokines in glial cells by trans-activation of human T cell lymphotropic virus type I. FEBS Lett., 31: 47-50.
26. Scott, A.I., Perini, A.F., Scering, P.A. and Whalley, L.J. (1991) In-patient major depression: Is rolipram as effective as amitriptyline? Eur. J. Clin. Pharmacol., 40: 127-129.
27. Selmaj, K.W., Farooq, M., Norton, W.T., Raine, C.S. and Brosnan, C.F. (1990) Proliferation of astrocyte in vitro in response to cytokines: a primary role for tumor necrosis factor. J. Immunol., 144: 129-135.
28. Selmaj, K.W. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol., 23: 339-346.
29. Semmler, J., Wachtel, H. and Enders, S. (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int. J. Immunopharmacol., 15: 409-413.
30. Siekevitz, M., Feinberg, M.B., Holbrook, N., Wong-Staal, F. and Greene, W.C. (1987) Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA, 84: 5389-5393.
31. Sommer, N., Loschmann, P.A., Northoff, G.H., Weller, M., Steinbrecher, A., Steinbach, J.P., Lichtenfels, R., Meyermann R., Riethmüller, A., Fontana, A., Dichgans, J. and Martin, R. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med., 1: 244-248.
32. Tendler, C.L., Greenberg, S.J., Blattner, W.A., Manns, A., Murphy, E., Fleisher, T., Manchard, B., Morgan, O., Burton, J.D., Nelson, D.L. and Waldmann, T.A. (1990) Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA, 87: 5218-5222.
33. Tschachler, E., Robert-Gurrof, M., Gallo, R.C. and Reitz, M.S., Jr. (1989) Human T lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood, 73: 194-201.
34. Umehara, F., Izumo, S., Ronquillio, A.T., Matsumuro, K., Sato, E. and Osame, M. (1994) Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol., 53: 72-77.
35. Vass, K., Heininger, K., Schafer, B., Linington, C. and Lastmann, H. (1992) Interferon-γ potentiates antibody-mediated demyelination in vitro. Ann. Neurol., 32: 198-206.
36. Verghese, M.W., McConnell, R.T., Strickland, A.B., Gooding, R.C., Stimpson, S.A., Yarnall, D.P., Taylor, J.D. and Furdon, P.J. (1995) Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J. Pharmacol. Exp. Ther., 272: 1313-1320.
37. Watanabe, H., Nakamura, T., Nagasato, K., Shirabe, S., Ohishi, K., Ichinose, K., Nishiura, Y., Chiyoda, S., Tsujihata, M. and Nagataki, S. (1995) Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotrophic virus type I-associated myelopathy. Arch. Neurol., 52: 276-280.
38. Yamamoto, N., Okada, M., Koyanagi, M., Kannagi, M. and Hinuma, Y. (1982) Transformation of human leukocytes by co-cultivation with an adult T-cell-leukemia-virus-producer cell line. Science, 217: 737-739.
39. Yokota, S., Geppert, T.D. and Lipsky, P.E. (1988) Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J. Immunol., 140: 531-536.
40. Yoshida, M., Miyoshi, I. and Hinuma, Y. (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA, 79: 2031-2035.